Skip to main content

Advertisement

SpringerLink
Log in

Pituitary tumor registry: a multidisciplinary program protocol

  • Study Protocol
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Purpose

This registry aims to collect information to create an appropriate platform for the development of a basis for clinical research and basic sciences to carefully study pituitary adenomas.

Methods

Demographic data, diagnosis, treatment, and outcome information of the patients with a confirmed diagnosis of pituitary adenomas will be collected by investigators of the registry. Analysis of registry data generates aggregate reports summarizing pituitary tumor epidemiology, treatment, and outcome. These reports include annual public data reports. In the future, the registry program may provide a wider network in Iran and ultimately support the expansion of international studies.

Conclusion

For a long time, patients with pituitary adenomas should be observed. Implementing a registration system would greatly reduce the challenges of patients’ follow-up so that their monitoring can be improved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gsponer J, De Tribolet N, Déruaz JP, Janzer R, Uské A, Mirimanoff RO, et al. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients. Medicine (Baltimore). 1999;78(4):236–69.

  2. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol. 2007;156(2):203–16.

    Article  CAS  PubMed  Google Scholar 

  3. Snyder PJ. Gonadotroph and other clinically nonfunctioning pituitary adenomas. Cancer Treat Res. 1997;89:57–72.

    Article  CAS  PubMed  Google Scholar 

  4. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege. Belgium J Clin Endocrinol Metab. 2006;91(12):4769–75.

    Article  CAS  PubMed  Google Scholar 

  5. Russ S, Anastasopoulou C, Shafiq I. Pituitary Adenoma. 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.

  6. Zielinski G, Ozdarski M, Maksymowicz M, Szamotulska K, Witek P. Prolactinomas: prognostic factors of early remission after transsphenoidal surgery. Front Endocrinol (Lausanne). 2020;7(11):439.

    Article  Google Scholar 

  7. Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L, et al. A pituitary society update to acromegaly management guidelines. Pituitary. 2021;24(1):1–13.

    Article  PubMed  Google Scholar 

  8. Hinojosa-Amaya JM, Cuevas-Ramos D. The definition of remission and recurrence of Cushing’s disease. Best Pract Res Clin Endocrinol Metab. 2021;35(1):101485.  https://doi.org/10.1016/j.beem.2021.101485.

  9. Drange MR, Fram NR, Herman-Bonert V, Melmed S. Pituitary tumor registry: a novel clinical resource. J Clin Endocrinol Metab. 2000;85(1):168–74.

    CAS  PubMed  Google Scholar 

  10. Berkmann S, Schütz P, Röthlisberger M, Mariani L, Kothbauer K, Fischli S, et al. The Swiss Pituitary Registry—SwissPit. J Neurol Surg A Cent Eur Neurosurg. 2018;79(S 01):O18.

  11. Khamseh ME, Mohajeri Tehrani MR, Mousavi Z, Malek M, Imani M, Hoshangian Tehrani N, et al. Iran pituitary tumor registry: description of the program and initial results. Arch Iran Med. 2017;20(12):746–51.

    PubMed  Google Scholar 

  12. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro Oncol. 1999;1(1):14–25.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Pituitary Registry program was supported by Tehran University of Medical Sciences and Endocrinology and Metabolism Research Institute.

Author information

Author notes

  1. Shahrzad Mohseni and Amir-Mohammad Asgari contributed equally to this work.

Authors and Affiliations

  1. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Shariati Hospital, Tehran University of Medical Sciences, Fifth Floor, North Kargar Ave., Tehran, Iran

    Shahrzad Mohseni, Amir-Mohammad Asgari, Mahnaz Pejman Sani, Mohammadreza Mohajeri-Tehrani & Bagher Larijani

  2. Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Saeedeh Saeedi

  3. Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Afshin Ostovar

  4. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular- Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Fatemeh Bandarian

Authors
  1. Shahrzad Mohseni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amir-Mohammad Asgari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saeedeh Saeedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Afshin Ostovar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fatemeh Bandarian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahnaz Pejman Sani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mohammadreza Mohajeri-Tehrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Mahnaz Pejman Sani or Mohammadreza Mohajeri-Tehrani.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohseni, S., Asgari, AM., Saeedi, S. et al. Pituitary tumor registry: a multidisciplinary program protocol. J Diabetes Metab Disord 22, 1801–1804 (2023). https://doi.org/10.1007/s40200-023-01306-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-023-01306-1

Keywords

Search

Navigation